A 100% premium from the current price for buyout seems a bit a rich to me. Would love it, but I think I'm closer to $70 for a near term buyout (next couple of months) given the current biotech landscape.
Trading down with biotech in general which is being slaughtered. NBIX's future depends on VMAT results due out in the next week or two. If positive (which many expect with no guarantees), all will be fine.
Bier, careful on Linn. Don't know alot about it, but see this article today: